FundedIQ
Biotechnology

Tectonic Therapeutic: Funding, Investors & Team (Oct 2026)

Tectonic is a privately held biotechnology company that aims to transform the discovery of novel GPCR-targeted drugs and unlock the therapeutic utility the most challenging receptors in the class. Tectonic’s founders are at the forefront of scientific research in biochemistry and molecular pharmacology with an extensive track record of entrepreneurial achievement.

tectonictx.com LinkedIn Allston, United States 11-50 employees
Total raised
$80.0M
Rounds
1
Latest
Series A
Apr 2021

Tectonic Therapeutic has raised $80.0M across 1 funding round on record, the most recent a Series A of $80.0M announced in Apr 2021.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Tectonic Therapeutic Company Profile and Key Stats

Total funding raised
$80.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$80.0M in Apr 2021
Employees
11-50
reported band
Headquarters
Allston, United States

Latest funding round on record: Apr 2021.

Tectonic Therapeutic Funding Rounds

Date
Round
Amount
Series A
$80.0M

Tectonic Therapeutic Founders and Leadership Team

Name
Role
Contact
Alise Reicin
CEO
—

No contact details are on record for this team yet.

Tectonic Therapeutic Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M
8,558
$15M

Tectonic Therapeutic's latest round of $80.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Tectonic Therapeutic in Biotechnology and Allston

Companies Similar to Tectonic Therapeutic

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Tectonic Therapeutic Funding FAQs

What does Tectonic Therapeutic do?

Tectonic is a privately held biotechnology company that aims to transform the discovery of novel GPCR-targeted drugs and unlock the therapeutic utility the most challenging receptors in the class. Tectonic’s founders are at the forefront of scientific research in biochemistry and molecular pharmacology with an extensive track record of entrepreneurial achievement.

How much funding has Tectonic Therapeutic raised?

Tectonic Therapeutic has raised $80.0M across 1 round on record. The most recent is a Series A of $80.0M announced in Apr 2021.

When did Tectonic Therapeutic last raise funding?

Tectonic Therapeutic's most recent funding round on record is a Series A of $80.0M, announced in Apr 2021.

Who is the CEO of Tectonic Therapeutic?

Alise Reicin is listed as CEO at Tectonic Therapeutic.

Where is Tectonic Therapeutic headquartered?

Tectonic Therapeutic is based in Allston, Massachusetts, United States.

How many employees does Tectonic Therapeutic have?

Tectonic Therapeutic is in the 11-50 employee band.

How does Tectonic Therapeutic's funding compare to other Biotechnology startups?

Tectonic Therapeutic's latest round of $80.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Tectonic Therapeutic Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Tectonic Therapeutic is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.